ABL Texcell Diagnostics Raises FY26 Revenue View
ABL Texcell Diagnostics has raised its FY26 revenue forecast to EUR13.5 million - EUR14 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.